H.B. Fuller Company

H.B. Fuller Company (FUL) Market Cap

H.B. Fuller Company has a market capitalization of $3.43B.

Financials based on reported quarter end 2026-02-28

Price: $63.02

-0.19 (-0.30%)

Market Cap: 3.43B

NYSE · time unavailable

CEO: Celeste Beeks Mastin

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1968-04-25

Website: https://www.hbfuller.com

H.B. Fuller Company (FUL) - Company Information

Market Cap: 3.43B · Sector: Basic Materials

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives such as, thermoplastic, thermoset, reactive, and water-based and solvent-based products for applications in various markets, including food and beverage containers, flexible packaging, consumer goods, package integrity and re-enforcement, and non-durable goods; corrugation, folding carton, tape and label, paper converting, envelopes, books, multi-wall bags, sacks, and tissue and towel; disposable diapers, feminine care, and medical garments; and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives such as reactive, light cure, two-part liquids, silicone, polyurethane, film, and fast cure products to the appliances and filters, windows, doors and wood flooring, and textile, transportation, electronics, medical, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly through distributors and retailers. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Analyst Sentiment

66%
Buy

Based on 15 ratings

Analyst 1Y Forecast: $71.00

Average target (based on 3 sources)

Consensus Price Target

Low

$63

Median

$73

High

$84

Average

$73

Potential Upside: 16.4%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HB FULLER (FUL) — Investment Overview

🧩 Business Model Overview

HB Fuller (FUL) is a global formulater, manufacturer, and marketer of adhesives, sealants, and other specialty chemical products. The company serves a broad range of industrial, consumer, and construction markets worldwide, positioning itself as a critical solutions provider for bonding, sealing, and performance-enhancement needs across diverse applications. HB Fuller’s business model is built upon deep technical expertise, close customer collaboration, and continuous innovation, enabling the creation of tailored adhesive solutions that are integral to customer operations. Its scale, technical support, and global sales network underpin efficient customer reach and responsiveness, allowing the company to both defend incumbency and seize new growth opportunities across economies.

💰 Revenue Streams & Monetisation Model

HB Fuller's revenues derive from the sale of adhesive and sealant products, generated through both recurring contractual relationships and transactional purchases. The company segments its business into key end-markets including Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. These divisions supply diverse sectors such as packaging, hygiene products, woodworking, automotive, electronics, construction, and more. The monetisation model is product-centric, with revenues typically earned on a per-unit or per-volume basis. Complementary services such as technical support, collaborative product development, and process optimisation consulting serve both as value-added offerings and differentiating features that foster stickiness and encourage long-term partnerships. Aside from direct sales, HB Fuller also accesses customers through distributors and agents in certain markets, expanding its reach and reducing go-to-market friction in fragmented geographies.

🧠 Competitive Advantages & Market Positioning

HB Fuller’s competitive moat is supported by several key factors. First, the adhesive industry demands advanced formulation capabilities and deep know-how in chemistry, positioning HB Fuller’s R&D efforts as a significant barrier to entry. Its longstanding customer relationships, often built through co-developed or custom-engineered solutions, create switching costs and solidify entrenched positions within customer supply chains. The company’s global manufacturing and distribution footprint ensures supply security and responsiveness, a critical consideration for multinational customers operating just-in-time or lean inventories. Furthermore, HB Fuller’s diversified end-market exposure limits concentration risk and helps smooth cyclicality that may afflict individual end segments. From a market positioning standpoint, HB Fuller is typically seen as a top player (generally ranking behind Henkel and Sika) in several adhesive submarkets, but possesses scale and breadth that regional or niche competitors often cannot match. Its focus on high-value, solution-based sales rather than commoditized volume business contributes to above-industry-average margins in select verticals.

🚀 Multi-Year Growth Drivers

Several durable trends support HB Fuller’s long-term growth trajectory: - **Secular Adoption of Lightweight and Sustainable Materials:** Increased use of advanced adhesives in automotive, electronics, and packaging reduces reliance on mechanical fasteners, driving content-per-unit expansion. - **Hygiene and Health Product Demand:** Demographic and lifestyle shifts globally—particularly in emerging markets—bolster consumption of hygiene products reliant on specialty adhesives. - **Green Chemistry and Regulatory Shifts:** Rising global regulatory standards for low-VOC and non-toxic adhesives require ongoing innovation, benefiting proven incumbents with advanced R&D resources. - **Geographic and End-Market Diversification:** Strategic acquisitions and organic expansion enable participation in high-growth markets and reduce exposure to economic volatility within single regions or sectors. - **Value-Added Product Innovation:** The trend towards customizable, high-performance adhesives opens opportunities for margin accretive new product development, often accompanied by long-term supply agreements and cross-selling opportunities.

⚠ Risk Factors to Monitor

Key risks associated with an investment in HB Fuller include: - **Raw Material Volatility:** Many chemical feedstocks are petroleum-derived and exhibit price volatility, creating input cost pressure that may not be immediately recoverable through pricing. - **Competitive Environment:** The adhesives industry remains highly competitive, with several global and numerous regional players vying for share, which can pressure margins if pricing discipline erodes. - **Customer Concentration and Cyclicality:** Exposure to cyclical end-markets or large customers can impact results if demand falters or customer relationships are lost for strategic or commercial reasons. - **Regulatory and Environmental Liabilities:** As a producer of chemicals, HB Fuller is subject to extensive environmental laws and product regulation, raising the risk of unforeseen compliance costs or litigation. - **Execution on Acquisition Integration:** Frequent acquisitions as part of the company’s growth strategy entail risks around integration, realization of expected synergies, and potential cultural or operational mismatches.

📊 Valuation & Market View

In evaluating HB Fuller’s valuation, typical analyst approaches include forward and trailing EBITDA and earnings multiples relative to both peers and the company’s own historical range. The company’s underlying attributes—margin stability, cash flow generation, and end-market resilience—are often reflected in premium-to-industry-average valuations, although not to the extent of faster-growing specialty chemical bellwethers. Valuation frameworks also consider free cash flow yield, reflecting the company’s capital-light nature and recurring revenue mix. The market’s key focus areas usually include the sustainability of volume growth, margin trajectories amid raw material cost shifts, and capacity for further value-accretive M&A. HB Fuller’s leverage and capital allocation policy are frequently scrutinized to assess the balance between reinvestment for growth, deleveraging, and returning capital to shareholders.

🔍 Investment Takeaway

HB Fuller occupies an attractive niche within the specialty chemicals sector, offering a blend of recurring, recession-resistant demand, diversified end-market exposure, and technological depth. Its growth prospects are propelled by innovation in high-performance applications, increasing demand for sustainable solutions, and expansion into new geographies and verticals. Meanwhile, operational discipline and portfolio management support consistent cash generation. Investors should balance these strengths against cyclicality in certain end-markets, ongoing input price volatility, integration risk from acquisitions, and the threat of intensifying competition. However, for long-term investors seeking exposure to value-added industrials with durable competitive positioning and multiple secular tailwinds, HB Fuller represents a compelling core holding.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

FUL’s Q1 2026 showed strong cost/mix execution despite volume contraction: adjusted EBITDA of $119M (+4% YoY) and EBITDA margin +90 bps to 15.4%, helped by restructuring (Quantum Leap) and pricing/raw-material actions versus a -6.6% organic revenue decline (pricing +0.6%, volume -7.2%). Management’s core 2026 update hinges on supply-chain shock from the Middle East (40+ force majeure letters), prompting a minimum 10% global price increase effective April 1 and ongoing supplements, with FY guidance raised on earnings power but assuming volume further deteriorates (now down ~5%). Analysts probed whether pricing assumptions remain valid, how much Lunar New Year timing distorted Q1/Q2, and what drives the HHC volume/inventory trend. The central “so what” is a constrained market that can enable share gains, but demand destruction plus customer input/substrate limitations keep volume downside material, increasing reliance on pricing and working-capital management to protect cash flow and margins.

AI IconGrowth Catalysts

  • Minimum 10% global price increase effective April 1, with higher pricing for certain technologies/regions to offset supply shock inflation and protect service levels
  • Market share opportunity from competitors facing raw material uncertainty; management believes they can gain allocation and secure qualified substitutes ahead of broader market
  • Selective share-gain execution by channeling scarce materials to customers that innovate with Fuller (ties to higher-margin spaces in EA and BAS, and HHC opportunities where China-sourced raw materials are directly impacted)
  • Project Quantum Leap redesigned plant and supply chain network remains on track to strengthen long-term competitiveness and improve profitability

Business Development

  • 3 large global existing customers (mentioned by Lucas Beaumont) asked Fuller to supply an additional application after their prior supplier couldn’t supply
  • Relationships and contracting with long-term specialty chemical suppliers (including China supply base); management referenced committing longer-term to suppliers able to supplement needs during force majeure conditions

AI IconFinancial Highlights

  • Organic revenue: -6.6% YoY (pricing +0.6%, volume -7.2%); currency +3.6%; acquisitions +0.7%
  • Adjusted EBITDA: $119,000,000, +4% YoY; EBITDA margin expanded +90 bps to 15.4% (restructuring savings from Quantum Leap + price/raw material actions outweighed lower volume)
  • Adjusted gross margin: 31.3%, +170 bps YoY (positive pricing/raw material actions + restructuring savings more than offset volume)
  • EA: organic revenue +~3% excluding solar/business exit; EBITDA margin +120 bps YoY to 19.9% (net pricing/raw material actions + restructuring)
  • HHC: organic revenue -10% YoY (customers tighter inventory; premium down-trading and smaller package sizes); EBITDA margin 13.9%, +120 bps YoY
  • BAS: organic sales -5.1% YoY; EBITDA -1% YoY; EBITDA margin flat (price/raw actions + restructuring savings offset volume declines)
  • Net debt/adjusted EBITDA: 3.1x (down from 3.5x at end of Q1 prior year)

AI IconCapital Funding

  • Paused near-term M&A closings; evaluating strategic acquisitions but pausing to deploy more cash into share repurchases while targeting net debt/EBITDA of 2.5x to 3.0x
  • Operating cash flow improved by $49,000,000 YoY in Q1; operating cash flow expected to be weighted to 2H 2026

AI IconStrategy & Ops

  • Deployed global sourcing and supply assurance infrastructure: securing raw materials ahead of broader market, reallocating volumes across regions, pursuing qualified substitutes
  • Swift pricing actions tied to raw material and energy/freight inflation; additional supplements negotiated on top of the 10% minimum
  • Execution/visibility into Project Quantum Leap redesign of plant and supply chain network remains on track
  • Inventory management approach may require living with higher inventory to improve supply assurance (per CFO discussion in Q&A)

AI IconMarket Outlook

  • FY 2026 guidance update: net revenue up mid-single digits; organic revenue up low single digits; FX translation expected to positively impact revenue by 1% to 2%
  • FY 2026 adjusted EBITDA: $645,000,000 to $675,000,000; FY 2026 adjusted EPS: $4.55 to $4.90
  • Q2 2026: net revenue up low single digits; adjusted EBITDA $175,000,000 to $185,000,000
  • Within FY 2026 volume framework (CFO/Q&A): pricing/raws drive roughly two-thirds of guidance change; volume assumption revised from flat to down 1% to down 5%

AI IconRisks & Headwinds

  • Middle East conflict supply-chain disruption: chemical capacity down significantly; tanker routes disrupted/repositioned; management cited receiving over 40 force majeure letters from suppliers
  • Broad inflationary pressure and raw material shortages expected to persist as inventories rebalance and logistics normalize (aftershocks through the year)
  • HHC demand pressure: customers tighter inventory management; consumers switching away from premium products; smaller package sizes reduce adhesive usage
  • Volume risk from demand erosion in inflationary environment and uncertainty around customers unable to source other substrates/inputs needed for end products
  • Energy/freight inflation and specialty chemical pricing reset dynamics; VAM spot market in Europe up ~300% recently
  • FX and working capital timing risk: CFO flagged managing inventory may be trickier; potential working capital drag is being monitored

Q&A: Analyst Interest

  • Topic: Price-cost assumption vs guidance cadence (10% price hike); Management's detailed response: Celeste and John said they are baking in additional price and raw material benefits but also negative volume. Two-thirds of the guidance change is pricing/EO raw actions and volume. Organic growth guided to low single digits with pricing averaging ~10%+ for the rest of 2026; volume assumption shifted to down ~5% from flat to down 1%.
  • Topic: HHC volume drivers and inventory tightening trend after Q1; Management's detailed response: Management attributed ongoing HHC pressure to consumer affordability stress. They described inventory management occurring at big customers and distributors, with smaller customers affected by tariffs and inflation. Consumer down-trading to less premium products reduces adhesive usage and shifts demand toward smaller package sizes, lowering glue volume.
  • Topic: Lunar New Year timing, Asia activity, and link to Middle East conflict; Management's detailed response: They quantified Chinese New Year impact of about $15M–$20M revenue in Q1, which rolls into Q2 guidance (Q2 impact roughly ~$20M). Management said China bounced back to double-digit growth excluding Chinese New Year; in January they observed motivated demand and HHC outperformance in Asia driven by hygiene export growth and focus away from lower-cost baby diapers toward higher-end femcare/adult incontinence.

Sentiment: MIXED

Note: This summary was synthesized by AI from the FUL Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (FUL)

© 2026 Stock Market Info — H.B. Fuller Company (FUL) Financial Profile